Volume | 11,455 |
|
|||||
News | - | ||||||
Day High | 0.50 | Low High |
|||||
Day Low | 0.424 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Evoke Pharma Inc | EVOK | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.424 | 0.424 | 0.50 | 0.475 | 0.431 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
110 | 11,455 | US$ 0.461712 | US$ 5,289 | - | 0.40 - 1.96 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:45:39 | 95 | US$ 0.4898 | USD |
Evoke Pharma Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.24M | 8.48M | - | 5.18M | -7.79M | -0.92 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Evoke Pharma News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EVOK Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.45 | 0.50 | 0.40 | 0.438563 | 31,072 | 0.025 | 5.56% |
1 Month | 0.4743 | 0.55 | 0.40 | 0.4590202 | 36,075 | 0.0007 | 0.15% |
3 Months | 0.704 | 0.76 | 0.40 | 0.5484513 | 35,355 | -0.229 | -32.53% |
6 Months | 1.23 | 1.45 | 0.40 | 0.6997625 | 43,089 | -0.755 | -61.38% |
1 Year | 1.67 | 1.96 | 0.40 | 0.9534995 | 31,680 | -1.20 | -71.56% |
3 Years | 1.26 | 5.96 | 0.2261 | 1.12 | 570,529 | -0.785 | -62.30% |
5 Years | 0.60 | 6.0628 | 0.2261 | 1.70 | 555,236 | -0.125 | -20.83% |
Evoke Pharma Description
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa. |